These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20726319)

  • 1. Levels of chemokine receptors expressed on peripheral blood T lymphocytes of Egyptian patients with hepatocellular carcinoma.
    Allam MM; Abd El Moneim E; Hassouna MM; El Jaky A; Zaghlah H
    Egypt J Immunol; 2009; 16(1):17-25. PubMed ID: 20726319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection.
    Lichterfeld M; Leifeld L; Nischalke HD; Rockstroh JK; Hess L; Sauerbruch T; Spengler U
    J Infect Dis; 2002 Jun; 185(12):1803-7. PubMed ID: 12085329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes.
    Zahran AM; Hetta HF; Rayan A; Eldin AS; Hassan EA; Fakhry H; Soliman A; El-Badawy O
    Cancer Immunol Immunother; 2020 Jul; 69(7):1253-1263. PubMed ID: 32170378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma.
    Liu Y; Poon RT; Feng X; Yu WC; Luk JM; Fan ST
    Am J Gastroenterol; 2004 Jun; 99(6):1111-21. PubMed ID: 15180734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion.
    Wu X; Fan J; Wang X; Zhou J; Qiu S; Yu Y; Liu Y; Tang Z
    Biochem Biophys Res Commun; 2007 Apr; 355(4):866-71. PubMed ID: 17336272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine-Regulated Recruitment of Antigen-Specific T-Cell Subpopulations to the Liver in Acute and Chronic Hepatitis C Infection.
    Pirozyan MR; Nguyen N; Cameron B; Luciani F; Bull RA; Zekry A; Lloyd AR
    J Infect Dis; 2019 Apr; 219(9):1430-1438. PubMed ID: 30496498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.
    Zhu Y; Gao XM; Yang J; Xu D; Zhang Y; Lu M; Zhang Z; Sheng YY; Li JH; Yu XX; Zheng Y; Dong QZ; Qin LX
    Cancer Sci; 2018 Mar; 109(3):710-723. PubMed ID: 29285854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic HCV-infection and expression of mRNA of CC-chemokines and their receptors].
    Zhdanov KV; Gusev DA; Chirskiĭ VS; Sysoev KA; Iakubovskaia LA; Shakhmanov DM; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (4):73-8. PubMed ID: 18822499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice.
    Barashi N; Weiss ID; Wald O; Wald H; Beider K; Abraham M; Klein S; Goldenberg D; Axelrod J; Pikarsky E; Abramovitch R; Zeira E; Galun E; Peled A
    Hepatology; 2013 Sep; 58(3):1021-30. PubMed ID: 23526353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
    El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
    APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cytokine levels and increased CD4+CD57+ T cells in the peripheral blood of hepatitis C virus-related hepatocellular carcinoma patients.
    Shiraki T; Takayama E; Magari H; Nakata T; Maekita T; Enomoto S; Mori Y; Shingaki N; Moribata K; Deguchi H; Ueda K; Inoue I; Mizuno-Kamiya M; Yashiro K; Iguchi M; Tamai H; Kameyama Y; Kato J; Kondoh N; Ichinose M
    Oncol Rep; 2011 Jul; 26(1):201-8. PubMed ID: 21491089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
    Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
    J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma.
    Thimme R; Neagu M; Boettler T; Neumann-Haefelin C; Kersting N; Geissler M; Makowiec F; Obermaier R; Hopt UT; Blum HE; Spangenberg HC
    Hepatology; 2008 Dec; 48(6):1821-33. PubMed ID: 19003875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
    Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
    J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral γδ T-Cell Infiltrates, Chemokine (C-C Motif) Ligand 4/Chemokine (C-C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma.
    Zhao N; Dang H; Ma L; Martin SP; Forgues M; Ylaya K; Hewitt SM; Wang XW
    Hepatology; 2021 Mar; 73(3):1045-1060. PubMed ID: 32502310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
    Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.
    Nada O; Abdel-Hamid M; Ismail A; El Shabrawy L; Sidhom KF; El Badawy NM; Ghazal FA; El Daly M; El Kafrawy S; Esmat G; Loffredo CA
    J Clin Virol; 2005 Oct; 34(2):140-6. PubMed ID: 16157266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infection.
    Nansen A; Marker O; Bartholdy C; Thomsen AR
    Eur J Immunol; 2000 Jul; 30(7):1797-806. PubMed ID: 10940868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.